Federal contract award
75F40119C10139
THIS PROJECT FALLS IN THE CATEGORIES OF BASIC AND APPLIED RESEARCH. THE TWO OBJECTIVES ARE (A) TEST THE HYPOTHESIS THAT UNAVOIDABLE VARIABILITIES IN THE PROPERTIES OF NP AND THE INTENDED TARGET SITE (SOLID TUMORS) CAUSE UNCERTAINTIES IN "FORMULA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $1.8M |
| Current contract value | $1.8M |
| Potential contract value / ceiling | $1.8M |
| Start date | Sep 25, 2019 |
| Current end date | Mar 26, 2025 |
| Potential end date | Mar 26, 2025 |
| Latest award activity | Jul 12, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 12, 2026 | P00010 | $-130.2K | PERFORMANCE OF STUDY ENTITLED "MIDD APPROACH TO IDENTIFY CRITICAL QUALITY ATTRIBUTES AND SPECIFICATIONS FOR GENERIC NANOTECHNOLOGY PRODUCTS." |
| Jul 9, 2024 | P00009 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO MARCH 26, 2025. ALL OTHER TERMS AND CONDITIONS ARE UNCHANGED |
| Mar 20, 2024 | P00008 | $0 | MOD P00008 - THE PURPOSE OF THIS MODIFICATION IS TO CORRECT THE DATES ON LINE ITEM 4 AND DELIVERY OF LINE ITEM 4 TO REFLECT THE CORRECT DATE OF 09/26/2024. ALL OTHER TERMS AND CONDITIONS ARE UNCHANGED |
| Aug 1, 2023 | P00007 | $0 | MIDD APPROACH TO IDENTIFY CRITICAL QUALITY ATTRIBUTES AND SPECIFICATIONS FOR GENERIC NANOTECHNOLOGY PRODUCTS |
| May 5, 2023 | P00006 | $490.7K | MIDD APPROACH TO IDENTIFY CRITICAL QUALITY ATTRIBUTES AND SPECIFICATIONS FOR GENERIC NANOTECHNOLOGY PRODUCTS |
| Aug 26, 2022 | P00005 | $0 | MIDD APPROACH TO IDENTIFY CRITICAL QUALITY ATTRIBUTES AND SPECIFICATIONS FOR GENERIC NANOTECHNOLOGY PRODUCTS |
| Dec 14, 2021 | P00004 | $516.9K | EXERCISE OPTION 2 - THIS PROJECT FALLS IN THE CATEGORIES OF BASIC AND APPLIED RESEARCH. THE TWO OBJECTIVES ARE (A) TEST THE HYPOTHESIS THAT UNAVOIDABLE VARIABILITIES IN THE PROPERTIES OF NP AND THE INTENDED TARGET SITE (SOLID TUMORS) CAUSE UNCERTAINT |
| Apr 23, 2021 | P00003 | $186.4K | THIS PROJECT FALLS IN THE CATEGORIES OF BASIC AND APPLIED RESEARCH. THE TWO OBJECTIVES ARE (A) TEST THE HYPOTHESIS THAT UNAVOIDABLE VARIABILITIES IN THE PROPERTIES OF NP AND THE INTENDED TARGET SITE (SOLID TUMORS) CAUSE UNCERTAINTIES IN "FORMULA |
| Dec 24, 2020 | P00002 | $263.1K | THIS PROJECT FALLS IN THE CATEGORIES OF BASIC AND APPLIED RESEARCH. THE TWO OBJECTIVES ARE (A) TEST THE HYPOTHESIS THAT UNAVOIDABLE VARIABILITIES IN THE PROPERTIES OF NP AND THE INTENDED TARGET SITE (SOLID TUMORS) CAUSE UNCERTAINTIES IN "FORMULA |
| Jun 15, 2020 | P00001 | $0 | THIS PROJECT FALLS IN THE CATEGORIES OF BASIC AND APPLIED RESEARCH. THE TWO OBJECTIVES ARE (A) TEST THE HYPOTHESIS THAT UNAVOIDABLE VARIABILITIES IN THE PROPERTIES OF NP AND THE INTENDED TARGET SITE (SOLID TUMORS) CAUSE UNCERTAINTIES IN "FORMULA |
| Sep 25, 2019 | 0 | $447.2K | THIS PROJECT FALLS IN THE CATEGORIES OF BASIC AND APPLIED RESEARCH. THE TWO OBJECTIVES ARE (A) TEST THE HYPOTHESIS THAT UNAVOIDABLE VARIABILITIES IN THE PROPERTIES OF NP AND THE INTENDED TARGET SITE (SOLID TUMORS) CAUSE UNCERTAINTIES IN "FORMULA |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.